| The cost burden of diabetes mellitus: the evidence from Germany—the CoDiM study I Köster, L Von Ferber, P Ihle, I Schubert, H Hauner Diabetologia 49 (7), 1498-1504, 2006 | 289 | 2006 |
| Prävalenz und zeitliche Entwicklung des bekannten Diabetes mellitus C Heidemann, Y Du, I Schubert, W Rathmann, C Scheidt-Nave Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 56 (5-6), 668-677, 2013 | 147 | 2013 |
| Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis-related symptoms: findings from a statutory health insurance-based … S Abbas, P Ihle, I Köster, I Schubert European Journal of Obstetrics & Gynecology and Reproductive Biology 160 (1 …, 2012 | 142 | 2012 |
| Increase in opiate prescription in Germany between 2000 and 2010: a study based on insurance data I Schubert, P Ihle, R Sabatowski Deutsches Ärzteblatt International 110 (4), 45, 2013 | 136 | 2013 |
| Community pharmacy–based pharmaceutical care for asthma patients S Mangiapane, M Schulz, S Mühlig, P Ihle, I Schubert, HC Waldmann Annals of Pharmacotherapy 39 (11), 1817-1822, 2005 | 131 | 2005 |
| Direct costs of diabetes mellitus in Germany–CoDiM 2000–2007 I Köster, E Huppertz, H Hauner, I Schubert Experimental and Clinical Endocrinology & Diabetes 119 (06), 377-385, 2011 | 121 | 2011 |
| Versorgungsforschung mit GKV-Routinedaten I Schubert, I Köster, J Küpper-Nybelen, P Ihle Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 51 (10), 1095-1105, 2008 | 116 | 2008 |
| Prevalence and temporal trend of known diabetes mellitus C Heidemann, Y Du, I Schubert, W Rathmann, C Scheidt-Nave Robert Koch-Institut, Epidemiologie und Gesundheitsberichterstattung, 2013 | 104 | 2013 |
| Adverse events requiring hospitalization within 30 days after outpatient screening and nonscreening colonoscopies C Stock, P Ihle, A Sieg, I Schubert, M Hoffmeister, H Brenner Gastrointestinal endoscopy 77 (3), 419-429, 2013 | 99 | 2013 |
| The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health … I Schubert, I Köster, G Lehmkuhl Deutsches Ärzteblatt International 107 (36), 615, 2010 | 99 | 2010 |
| Physicians’ knowledge of and compliance with guidelines: an exploratory study in cardiovascular diseases U Karbach, I Schubert, J Hagemeister, N Ernstmann, H Pfaff, HW Höpp Deutsches Ärzteblatt International 108 (5), 61, 2011 | 92 | 2011 |
| Trends in der Prävalenz und ambulanten Versorgung von Menschen mit Diabetes mellitus EAVAOK Hessen, KV Hessen, H Hauner, I Köster, I Schubert Dtsch Arztebl 104 (41), 2799-805, 2007 | 86 | 2007 |
| Prescribing potentially inappropriate medication (PIM) in Germany's elderly as indicated by the PRISCUS list. An analysis based on regional claims data I Schubert, J Küpper‐Nybelen, P Ihle, P Thürmann Pharmacoepidemiology and drug safety 22 (7), 719-727, 2013 | 80 | 2013 |
| Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany B Ultsch, I Köster, T Reinhold, A Siedler, G Krause, A Icks, I Schubert, ... The European Journal of Health Economics 14 (6), 1015-1026, 2013 | 78 | 2013 |
| Gesundheit von Kindern und Jugendlichen: Schwerpunktbericht der Gesundheitsberichterstattung des Bundes I Schubert, Robert-Koch-Institut Robert-Koch-Inst., 2004 | 74* | 2004 |
| Epidemiologische Methoden für die Versorgungsforschung G Glaeske, M Augustin, H Abholz, N Banik, B Brüggenjürgen, J Hasford, ... Gesundheitswesen 71 (10), 685-693, 2009 | 65 | 2009 |
| Versichertenstichprobe AOK Hessen/KV Hessen–Konzeption und Umsetzung einer personenbezogenen Datenbasis aus der Gesetzlichen Krankenversicherung P Ihle, I Köster, H Herholz, P Rambow-Bertram, T Schardt, I Schubert Das Gesundheitswesen 67 (08/09), 638-645, 2005 | 64 | 2005 |
| Interne Validierung von Diagnosen in GKV-Routinedaten: Konzeption mit Beispielen und Falldefinition I Schubert, P Ihle, I Köster Das Gesundheitswesen 72 (06), 316-322, 2010 | 61 | 2010 |
| Non‐antiarrhythmic drugs prolonging the QT interval: considerable use in seven countries F De Ponti, E Poluzzi, A Vaccheri, U Bergman, L Bjerrum, J Ferguson, ... British journal of clinical pharmacology 54 (2), 171-177, 2002 | 52 | 2002 |
| Estimation of disease incidence in claims data dependent on the length of follow‐up: a methodological approach S Abbas, P Ihle, I Köster, I Schubert Health services research 47 (2), 746-755, 2012 | 51 | 2012 |
